QWO® is the first and only FDA-approved injectable for the treatment of moderate to severe cellulite in the buttocks of adult women. For most women, over time their skin thins, fat cells enlarge and push against the skin, and the fibrous bands under the skin’s surface thicken and cause tension. These factors working together cause cellulite’s signature dimples on the thighs and buttocks.
QWO Clinical Data
Endo Aesthetics conducted the largest clinical trials in the history of cellulite investigation to help determine the safety and efficacy of QWO. These two identical trials enrolled 845 women in the United States, aged 18 or older, with moderate to severe cellulite in the buttocks. Reductions in cellulite severity were observed more frequently in the QWO group compared to the placebo group as measured by the investigator and patient cellulite severity scales. QWO may cause serious allergic reactions, including anaphylaxis, and injection site bruising. Please see Important Safety Information below for more details.